Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.
Impact of azithromycin treatment on macrophage gene expression in subjects with cystic fibrosis.
复制标题
DOI:
10.1016/j.jcf.2013.08.007
复制
发表时间:
2014-03
期刊:
影响因子:
--
通讯作者:
Feola DJ
中科院分区:
文献类型:
--
作者:
Cory TJ;Birket SE;Murphy BS;Hayes D Jr;Anstead MI;Kanga JF;Kuhn RJ;Bush HM;Feola DJ
Azithromycin treatment improves clinical parameters in patients with CF, and alters macrophage activation from a pro-inflammatory (M1) phenotype to a pro-fibrotic, alternatively activated (M2) phenotype. The transcriptional profile of cells from patients receiving azithromycin is unknown. Gene expression in association with macrophage polarization, inflammation, and tissue remodeling was assessed from sputum samples collected from patients with CF. Transcriptional profiles and clinical characteristics, including azithromycin therapy, were compared. Expression of NOS2 and TNFα was decreased in subjects receiving azithromycin, whereas expression of M2-associated genes was unaffected. Principal component analysis revealed gene expression profiles consistent with M1-(MMP9, NOS2, and TLR4) or M2-polarization (CCL18, fibronectin, and MR1) in select subject groups. These expression signatures did not significantly correlate with clinical characteristics. Pro-inflammatory gene expression was low in subjects receiving AZM. Genes stratified to components characteristic of M1- or M2-polarization, suggesting overall polarization status is distinct among patient groups.